Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Schibsted in conjunction with investment in Savr
Mandate

Vinge advises Schibsted in conjunction with investment in Savr

March 08, 2022 M&A Banking and Finance Intellectual Property

Vinge has advised Schibsted in conjunction with its investment in Savr AB. The investment round, which is headed by Schibsted, will cotribute SEK 162 million to the company. Savr is a fund platform which repays all fund commission to its customers.

Vinge’s team consisted primarily of Johan Winnerblad, Emma Stuart-Beck, Henrik Schön, Caroline Krassén, Anton Sjökvist and Sofia Bergenstråhle.

Related

Vinge has advised Vimian Group AB in connection with its uplisting to Nasdaq Stockholm

Vinge has advised Vimian Group AB (publ) in connection with its list change from Nasdaq First North Growth Market to Nasdaq Stockholm’s main market, Large cap. The prospectus was published on 21 March 2025 and the trading on Nasdaq Stockholm commenced on 28 March 2025.
March 28, 2025

Vinge advises Tribune Therapeutics in conjunction with financing round

 Vinge advises Tribune Therapeutics, a Swedish biotechnology company focused on developing therapies for fibrotic diseases, in raising 23 MEUR. The financing round includes the previous investors HealthCap, Novo Holding and Innovestor, in addition to the new investors LifeArc Ventures, Industrifonden and Investinor.
March 26, 2025

Vinge advises Dignitana on the public offer from Paxman

 Paxman AB (publ) has announced a public offer to the shareholders of Dignitana AB. The total value of the offer is approximately SEK 153 million.
March 24, 2025